RLX Technology Inc. (RLX) is a Medicinal Chemicals and Botanical Products company listed on NYSE. There were no new wire items for RLX in the last 30 days. The most recent was published Aug 14, 2026.

RLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.

RLX rankings

Financial highlights

Full financials
Revenue, FY2025
CN¥3.96B
Revenue growth
+44.0%
Net income, FY2025
CN¥921.87M
Net margin
23.3%
Free cash flow, FY2025
CN¥986.82M
Cash
CN¥5.37B

For fiscal 2025 (ended Dec 31, 2025), from SEC filings. Not investment advice.

News · 26 weeks70%
2026-05-10: 12026-05-17: 22026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 22026-08-09: 22026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 0
2026-05-102026-11-01
Mix290d
  • Earnings1(50%)
  • SEC Filings1(50%)

Latest news

25 items

RLX FAQ

11 questions
  • What does RLX Technology Inc. do?
    RLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.
  • What is the latest news on RLX?
    Quantisnow has not tracked any new filings, ratings or press releases for RLX in the last 30 days. The most recent wire item was published on August 14, 2026.
  • What is RLX revenue?
    RLX Technology Inc. (RLX) reported CN¥3.96B of revenue for fiscal 2025 (ended Dec 31, 2025). That is up 44.0% from the year before.
  • Is RLX profitable?
    Yes. RLX Technology Inc. earned CN¥921.87M in net income for fiscal 2025 (ended Dec 31, 2025), a net margin of 23.3%.
  • How much cash and debt does RLX have?
    RLX Technology Inc. reported CN¥5.37B in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does RLX stock trade?
    RLX Technology Inc. (RLX) is listed on NYSE.
  • What sector and industry is RLX in?
    RLX Technology Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.
  • When did RLX Technology Inc. go public?
    RLX Technology Inc. (RLX) completed its IPO in 2021.
  • What are analysts saying about RLX?
    Across the last 2 analyst actions on RLX Technology Inc., there were 0 upgrades and 1 downgrade. The most recent action was from Citigroup: Neutral with a $2.50 price target on 2025-03-17. Recent price targets range from $2.50 to $2.60.
  • What companies are similar to RLX?
    Notable peers in the same industry include PM (Philip Morris International Inc), BTI (British American Tobacco Industries p.l.c.), MO (Altria Group Inc.), DFTX (Definium Therapeutics Inc.), RGC (Regencell Bioscience Holdings Limited). Compare RLX side-by-side with any of them on Quantisnow.
  • How can I track RLX on Quantisnow?
    Quantisnow aggregates RLX Technology Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow RLX to receive live email and push alerts on every new disclosure.